Files
Download Full Text (288 KB)
Publication Date
4-2026
Disclaimer
These guidelines do not establish a standard of care to be followed in every case. It is recognized that each case is different and those individuals involved in providing health care are expected to use their judgment in determining what is in the best interests of the patient based on the circumstances existing at the time. It is impossible to anticipate all possible situations that may exist and to prepare guidelines for each. Accordingly, these guidelines should guide care with the understanding that departures from them may be required at times.
Objective of the Clinical Pathway
To provide care standards for patients with concern for cannabinoid hyperemesis syndrome (CHS). This pathway guides the diagnosis and management of patients undergoing evaluation and treatment for suspected or confirmed CHS.
Target Users
Physicians (Emergency Department, Urgent Care, Ambulatory, Hospitalists, Fellows, Resident Physicians); Nurse Practitioners; Physician Assistants; Pharmacists; Social Workers
Disciplines
Pediatrics
Recommended Citation
Children's Mercy Kansas City, "Cannabinoid Hyperemesis Syndrome" (2026). Clinical Pathways.
https://scholarlyexchange.childrensmercy.org/clinical_pathways/57
